Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
15 July 2021Website:
http://www.rapidmicrobio.comNext earnings report:
02 August 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | 19 min agoDividend
Analysts recommendations
Institutional Ownership
RPID Latest News
Rapid Micro Biosystems, Inc. (RPID) reported a quarterly loss of $0.31 per share, slightly higher than the Zacks Consensus Estimate of $0.29 per share but an improvement from the loss of $0.32 per share in the same quarter last year.
Rapid Micro Biosystems, Inc. (RPID) Q4 2023 Earnings Call Transcript
LOWELL, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release fourth quarter and full year 2023 financial results prior to the market open on Friday, March 1, 2024.
LOWELL, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the 42nd Annual J.P. Morgan Healthcare Conference.
LOWELL, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the following investor conferences in New York, NY:
Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to loss of $0.38 per share a year ago.
LOWELL, Mass., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release third quarter 2023 financial results prior to the market open on Friday, November 3, 2023.
LOWELL, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the Morgan Stanley 21st Annual Global Healthcare Conference.
Rapid Micro Biosystems, Inc. (NASDAQ:RPID ) Q2 2023 Earnings Call Transcript August 4, 2023 8:30 AM ET Company Participants Mike Beaulieu - Vice President of Investor Relations Rob Spignesi - CEO, President and Director Sean Wirtjes - Chief Financial Officer Conference Call Participants Yuko Oku - Morgan Stanley Dan Arias - Stifel Operator Ladies and gentlemen, thank you for standing by, and welcome to Rapid Micro Biosystems' Q2 2023 Earnings Call. [Operator Instructions] I would now like to turn the conference over to Mike Beaulieu.
Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.33 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to loss of $0.31 per share a year ago.
What type of business is Rapid Micro Biosystems?
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides installation and verification, technical training, and support services. Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications. The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.
What sector is Rapid Micro Biosystems in?
Rapid Micro Biosystems is in the Healthcare sector
What industry is Rapid Micro Biosystems in?
Rapid Micro Biosystems is in the Medical Devices industry
What country is Rapid Micro Biosystems from?
Rapid Micro Biosystems is headquartered in United States
When did Rapid Micro Biosystems go public?
Rapid Micro Biosystems initial public offering (IPO) was on 15 July 2021
What is Rapid Micro Biosystems website?
https://www.rapidmicrobio.com
Is Rapid Micro Biosystems in the S&P 500?
No, Rapid Micro Biosystems is not included in the S&P 500 index
Is Rapid Micro Biosystems in the NASDAQ 100?
No, Rapid Micro Biosystems is not included in the NASDAQ 100 index
Is Rapid Micro Biosystems in the Dow Jones?
No, Rapid Micro Biosystems is not included in the Dow Jones index
When does Rapid Micro Biosystems report earnings?
The next expected earnings date for Rapid Micro Biosystems is 02 August 2024